📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The utility of anti-Müllerian hormone in the diagnosis and prediction of loss of ovarian function following chemotherapy for early breast cancer. (2017)

First Author: Anderson RA

Attributed to: MRC Centre for Reproductive Health at the University of Edinburgh funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejca.2017.10.001

PubMed Identifier: 29117576

Publication URI: http://europepmc.org/abstract/MED/29117576

Type: Journal Article/Review

Volume: 87

Parent Publication: European journal of cancer (Oxford, England : 1990)

ISSN: 0959-8049